Mar 13, 2026 · The hormone therapy drugs elacestrant (Orserdu) and imlunestrant (Inluriyo) may be used to treat hormone receptor-positive, HER2-negative metastatic breast cancers that have an …

Feb 24, 2025 · This page lists cancer drugs approved by the Food and Drug Administration (FDA) for breast cancer. The list includes generic names, brand names, and common drug combinations, …

4 days ago · This episode, titled CDK4/6 Inhibitors in Metastatic Breast Cancer: Approvals and Clinical Considerations, features breast cancer panelists discussing the following critical questions: What are …

Here's a list of the approved drugs to treat breast cancer. Click on any of the medications for more info on indications, dosing and side effects.

Nov 13, 2021 · Find the most popular and affordable Breast Cancer medication. Save with or without insurance on brand and generic alternatives used to treat Breast Cancer.

On January 27, 2025, the FDA approved fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for unresectable or metastatic hormone receptor (HR)-positive, HER2-low (IHC 1+ or IHC...

Which breast cancer drugs are approved by the F.D.A.? Find all available therapies and drugs currently approved for breast cancer treatment.

Patients whose tumors express any level of hormone receptors (HRs) should be offered hormone therapy. In Basic settings, if no immunohistochemistry testing is available, clinicians may presume …

For HR-positive metastatic breast cancer, many medications will generally be used first before chemotherapy. These medications are called “hormonal drugs” and include fulvestrant and …

This booklet explains Medicare coverage of medically necessary cancer treatment supplies, services, and prescription drugs. For more information, visit Medicare.gov, or call 1-800-MEDICARE (1-800 …